Session 3:
Natural Products from Bench to Clinic
Tuesday, January 13, 2015: 8:30 AM-11:55 AM
California Ballroom AB
Conveners:
Frank Koehn - Pfizer World Wide R&D, Groton, CT
and
Soon-Kwang Hong - Mjyongji University, Yongin,
8:30 AM
Advancing new cell wall inhibitors towards clinical applications
Stefano Donadio, Naicons Srl, Milano, Italy
Stefano Donadio, Naicons Srl, Milano, Italy
8:55 AM
Ecumicin as a novel anti-tuberculosis drug
Joo-Won Suh1, Jin-Yong Kim2, Wei Gao3, Ying-Yu Jin4, Sang-Hyun Cho5, Alfred Goldberg6, Guido Pauli7, Hanki Lee4 and Scott Franzblau5, (1)Division of Bioscience and Bioinformatics/Center for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin, (2)Division of Bioscience and Bioinformatics, Myongji University, Yongin, (3)Department of Medicinal Chemistry and Pharmacognosy/Institute for Tuberculosis Research, University of Illinois at Chicago, Chicago, IL, (4)Center for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin, (5)Institute for Tuberculosis Research, University of Illinois at Chicago, Chicago, IL, (6)Department of Cell Biology, Harvard Medical School, Boston, MA, (7)Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, IL
Joo-Won Suh1, Jin-Yong Kim2, Wei Gao3, Ying-Yu Jin4, Sang-Hyun Cho5, Alfred Goldberg6, Guido Pauli7, Hanki Lee4 and Scott Franzblau5, (1)Division of Bioscience and Bioinformatics/Center for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin, (2)Division of Bioscience and Bioinformatics, Myongji University, Yongin, (3)Department of Medicinal Chemistry and Pharmacognosy/Institute for Tuberculosis Research, University of Illinois at Chicago, Chicago, IL, (4)Center for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin, (5)Institute for Tuberculosis Research, University of Illinois at Chicago, Chicago, IL, (6)Department of Cell Biology, Harvard Medical School, Boston, MA, (7)Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, IL
9:20 AM
Discovery and development of Surotomycin
Victoria Knight-Connoni, Cubist Pharmaceuticals, Inc., Lexington, MA
Victoria Knight-Connoni, Cubist Pharmaceuticals, Inc., Lexington, MA
9:45 AM
Natural product derived insecticides: Discovery and development of Spinetoram
Ute Galm, Nigel Mouncey, Babu Raman, Shreedharan Sriram, Shrinivasrao Mane, Nadaraj Palaniappan, James E. Dripps, Gary D. Crouse, Thomas C. Sparks, Paul Graupner, Paul Lewer and Don Hahn, Dow AgroSciences LLC, Indianapolis, IN
Ute Galm, Nigel Mouncey, Babu Raman, Shreedharan Sriram, Shrinivasrao Mane, Nadaraj Palaniappan, James E. Dripps, Gary D. Crouse, Thomas C. Sparks, Paul Graupner, Paul Lewer and Don Hahn, Dow AgroSciences LLC, Indianapolis, IN
10:40 AM
Novel antitumor substances from microbial origin
Takashi Sakai, Natural Product Lead Discovery Group, Eisai Co., Ltd., TSUKUBA-SHI
Takashi Sakai, Natural Product Lead Discovery Group, Eisai Co., Ltd., TSUKUBA-SHI
11:05 AM
Uncoupling neuroprotection from immunosuppression: The discovery of ILS-920
Edmund Graziani, Medicinal Chemistry, Pfizer, Groton, CT
Edmund Graziani, Medicinal Chemistry, Pfizer, Groton, CT
11:30 AM
Natural products: Bridging ancient medicine and synthetic biology
Esther Schmitt, Natural Products Unit, Novartis, Basel, Switzerland
Esther Schmitt, Natural Products Unit, Novartis, Basel, Switzerland
See more of: Invited Papers